Details of the Drug | DrugMAP

General Information of Drug (ID: DMUHZLZ)

Drug Name

CCI 15106

Indication

Disease Entry	ICD 11	Status	REF
Chronic obstructive pulmonary disease	CA22	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: DSM39E

References

1	ClinicalTrials.gov (NCT03235726) A Double-blind (Sponsor Unblind), Randomized, Placebo-controlled, Single and Repeat Escalating Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CCI15106 Inhalation Powder in Healthy Participants and Participants With Moderate Chronic Obstructive Pulmonary Disease (COPD) Including Evaluation of Environmental and Healthy By-stander Exposure Levels During Dosing. U.S.National Institutes of Health.